Keeping it meaningful and efficient:
GEOGRAPHIC COVERAGE: Worldwide
PRODUCT PORTFOLIO: VAMs, Niche, Complex Generics, Injectables
![20200224_141747 (002) 20200224_141747 (002)](https://pharma-synergy-conference.com/wp-content/uploads/2020/10/20200224_141747-002-1024x768.jpg)
Partnering Meetings
The match-making was based on the key specific criteria (therapeutic area, geography, in/out-licensing interests, etc) that allowed for the efficient and targeted partnering requests and conversations.
Professional Audience
The PharmaSynergy event offered high-quality structured networking with peers from 47 continents.
15% - CEO/MD/GM
47% - SVP/ Head of BD
38% - BD Manager Level
![Stage from the audience Stage from the audience](https://pharma-synergy-conference.com/wp-content/uploads/2020/04/Stage-from-the-audience-e1585839640590-1024x772.jpg)
Session Highlights
TOPICS AND HIGHLIGHTS
Advancing Strategy: portfolio development, growth strategies & value creation
How is the pandemic recalibrating licensing priorities and practices – are geographical interests and portfolio needs changing?
What is the formula for creating the winning regional brands?
Geographical outlook of the key growth markets, presented by the regional companies: TMENA, LATAM, EAEU/CIS